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Introduction: Intramedullary limb lengthening systems includemechanical systems (theAlbizzia nail and
the ISKD nail) as well as motorized systems with the Fitbone® (Wittenstein, Igersheim, Germany) and
the Precice® (Ellipse Technologies, Irvine, CA, USA) nails. We hypothesized that limb lengthening using
the Fitbone® nail was reliable, reproducible, and comfortable for the patient.
Patients and methods: Between 2010 and 2013, a prospective single-center, single-operator (FA) study
was conducted on patients who had undergone limb lengthening using the Fitbone® nail. The inclusion
criteria were length discrepancy of the limbs equal to or greater than 25 mm or a short stature. The
exclusion criteria were indications for cosmetic reasons and/or growth plates that were still open. The
lengthening parameters were assessed postoperatively and at the last follow-up. Lengthening was con-
sidered achieved when the lengthening objective did not differ by more than 5 mm. All complications
were noted. A statistical analysis was performed.
Results: Twenty-six Fitbone® nails were implanted in 23 patients, in the femur in 15 cases and the tibia
in 11 cases. The patients’ mean age was 22.5 years (range: 15–53 years) and the mean follow-up was 3.4
years (range: 2–5.3 years). The limb lengthening targeted was obtained in 23 cases (88%) and the mean
lengtheningwas45.3±18 mm(range: 20–80 mm). Themean time tohealingwas277±167 days (range:
86–638 days). The mean healing index was 73±57 days/cm for the femurs and 83.5±65 days/cm for
the tibias. The mean complication rate was 15.4%.
Discussion: This studyemphasizes thegoodshort-termresultsof thismotorized intramedullary lengthen-
ing system. An evaluation over the longer term and with a higher number of patients remains necessary.
Level of evidence: IV: uncontrolled, prospective, continuous study.. Introduction
Bone lengthening of the limbs is a therapeutic challenge encum-
ered by complications varying from 11% to 50% depending on the
tudy [1]. The intramedullary bone lengthening systems include
echanical systems (the Albizzia® and ISKD® nails) and more
ecently motorized systems with the Fitbone® (Wittenstein, Iger-
heim, Germany) and Precice® (Ellipse Technologies, Irvine, CA,
SA) nails [2–4]. Use of mechanical intramedullary implants has
educed the rate of septic complications and fractures of the length-
ning callus. However, control of the lengthening and the patients’
omfort remain problematic [5]. The preliminary results of theFitbone® system are encouraging and seem to prevent this type
of complication [6–8]. However, these results stem from series of
cases including fewer than ten patients for the independent studies
andareoften retrospective.Wehypothesized that limb lengthening
using the Fitbone® intramedullary nail was a reliable and repro-
ducible technique that was also comfortable for the patient. In this
context, the objective of this study was to provide a prospective
assessment of the clinical and radiological results of lengthening
the lower-limb using the Fitbone®.
2. Material and methods
Between 2010 and 2013, a single-center, single-operator (FA)
prospective study was conducted on patients who underwent
lower-limb lengthening with the Fitbone® nail. The inclusion crite-
ria were patients presenting length discrepancy of the limbs equal
to or greater than 25 mm or a short stature. The exclusion criteria
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here lower-limb lengthening for cosmetic reasons and/or growth
lates that were still open.
.1. Surgical technique
The patients underwent preoperative planning with the reverse
lanning method described by Baumgart [9] based on a long leg
lm taken by EOS® low-dose radiography. Limb length discrep-
ncy and the correction objective in the three dimensions were
recisely deﬁned. This also made it possible to deﬁne the level of
he osteotomy line, distal metaphyseal for the femur and proximal
etaphyseal for the tibia, as well as the implant position. Place-
ent of blocking screws was planned if necessary. The patient
as installed on a standard orthopaedic table on a plexiglas plate
quipped with a metallic grid so as to evaluate the mechanical axis
f the operated limb intraoperatively. Intramedullary reaming was
erformed through a metal working tube, thus preventing debris
nd ovalization of the entry point. The osteotomy was performed
ercutaneouslywith a 4-mmdrill and then anosteotomeaccording
o the postage-stamp technique. The nailwas connected to a recep-
or by a wire positioned subcutaneously. The mechatronic implant
sed, CE marked TAA® (telescope active actuator), can be used on
he tibia or the femur either retrograde or antegrade. It is available
n 11- and 13-mm diameters with a lengthening capacity up to 8
m.Thepatientswerenot immobilized. Physical therapywasbegun
he day after surgery. The patient carried out the lengthening with
n external transcutaneous command (Fig. 1) in three sessions per
ay corresponding to 1 mm of distraction.
.2. Follow-up
The patients were followed-up weekly during the distraction
hase during which partial weightbearing (20 kg) and immedi-
te mobilization were authorized. Weightbearing was increased
onthly depending on the progression of the callous. Finally, the
atients were seen 6 months after implant removal.
.2.1. Preoperative
The general data collected before surgery comprised age, gen-
er, the surgical site, etiology, the procedures correcting the
ssociated deformity, as well as the lengthening objective. The
adiological LDFA (lateral distal femoral angle) and MPTA (medial
roximal tibial angle) angles were also measured.
.2.2. Postoperative
The lengthening parameters assessed postoperatively were the
engthening achieved, the duration of distraction (days), the dis-
raction index (mm/day), the maturation index (days/cm), the
ealing index (days/cm), the length of the hospital stay (days), joint
Fig. 1. Different stages in the lengthening prorangeofmovementof the lower-limbat the last follow-up, return to
weightbearing, andreturn towalkingunassistedandwithcomplete
weightbearing (Fig. 2). The lengthening was considered achieved
when it did not differ by more than 5 mm from the initial objec-
tive. Bone healing was deﬁned by corticalization of at least three
sides of the callus on AP and lateral X-rays. Patient comfort dur-
ing the distraction phase was evaluated using a Visual Analog Scale
(VAS) and pain was scored from 0 to 10.
The Paley functional score was used for femur and tibial length-
ening [10].
The postoperative LDFA and MPTA angles were also measured
to assess the correction of the deformities in the frontal plane.
Intraoperative and postoperative complications were recorded,
as wasmaterial removal. The complicationswere classiﬁed accord-
ing to the Lascombes classiﬁcation [11] and according to the Paley
classiﬁcation as a simple problem (grade 1), an obstacle (grade 2),
and minor or major complications (grade 3) [12].
2.3. Statistical analysis
The descriptive analysiswas performed after having veriﬁed the
Gaussian distribution of the continuous variables. Chi2 tests were
carried out for the qualitative variables. The subgroups were com-
pared using Fisher exact tests for the quantitative variables and
the Mann-Whitney U-test for the qualitative variables. The P-value
indicating statistical signiﬁcance was 5%. The statistical analysis
was done using STATA SE v11.0 software (College Station, TX, USA).
3. Results (Table 1)
A total of 26 Fitbone® nails were implanted in 23 patients. In
15 patients, the femur was lengthened and in 11 cases the tibia.
The patients’ mean age was 22.5 years (range: 15–53 years) and
the mean follow-up was 3.4 years (range: 2–5.3 years). The etiolo-
gies requiring the lengthening procedure were congenital in nine
cases (34.6%), post-traumatic in 11 cases (42.3%), neurologic in two
cases (7.7%), tumoral in two cases (7.7%), post-pandiaphysitis dur-
ing childhood in one case (3.8%), and post-poliomyelitis in one case
(3.8%). At the last follow-up, all the patient’s material had been
removed at a mean 20±4.2 months (range: 14–26 months) after
it had been implanted. No complications, obstacles, or difﬁculties
were encountered.
3.1. Gain in lengthThe planned limb lengthening was obtained in 23 cases (88%),
for a mean gain of 45.3±18mm (range: 20–80mm) (Figs. 3 and 4).
Three patients presented a mean 8.6 mm of residual internal
limiting membrane (ILM), which was felt clinically by one patient.
cedures and calculation of their indices.
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.2. Distraction index and hospital stay duration
Distractionbeganamean7 daysafter surgerywithamean index
f 0.78±0.26 mm/day (range: 0.1–1.32 days) and a mean distrac-
ion period lasting 74.1 days (range: 26–421 mm/day). During this
eriod, the mean patient comfort evaluated by the VAS was 2.5
range: 0–4).
.3. Maturation (Fig. 5)
There was no statistically signiﬁcant difference in terms
f maturation index according to the different factors studied
nown to inﬂuence the results. The mean duration of matura-
ion was 203±176 days (range: 49–590 days) for the femurs
nd 259±183days for the tibias. The mean maturation index
able 1
adiological results and the incomplete lengthening index.
Minimum
Target lengthening (mm) 25
Difference (mm) 5
Lengthening achieved (mm) 20
Preop right aLDFA (◦) 79.0
Preop left aLDFA 76.0
Preop right mMTPA 80.0
Preop left mMTPA 74.0
Postop right aLDFA 78.2
Left postop aLDFA 77.2
Postop right aMTPA 87.70
Postop left aMTPA 78.0
Duration of hospital stay (days) 3
Healing index (d/cm) 23.75
Maturation index (d/cm) 11.38
Distraction index (mm/d) .10
Duration of distraction (days) 26
Duration of maturation (days) 49
Duration of healing (days) 86
Time to total weightbearing (days) 58
Time to walking (days) 4
LDFA: anatomical lateral distal femoral angle; aMPTA: anatomical medial proximal tibiaogies.
was 59.9±59.3 days/cm for femurs and 72.9±69.3 days/cm for
tibias.
3.4. Healing (Fig. 5)
The mean healing index was 73±57 days/cm for femurs and
83.5±65 days/cm for tibias. No statistically signiﬁcant difference
was found between tibias and femurs. Similarly, no statistically
signiﬁcantdifferencewas foundbetweenpatients presenting apre-
operative frontal deformity and the others.3.5. Correction of the deformity
In 11 cases, the axis deformity in the frontal planewas corrected.
In patients presenting a frontal mechanical axis deformity, the
Maximum Mean Standard deviation
80 45.3 18.1
10 7.50 3.5
80 43.2 18.1
102.0 85.7 7.5
92.0 82.8 4.2
101.2 89.3 4.3
92.0 87.2 4.0
88.2 83.0 3.6
86.7 82.1 3.9
95.20 90.9 3.8
88.1 85.1 4.7
10 5.4 2.2
185.50 77.3 59.0
168.00 65.1 61.4
1.32 0.7 0.2
421 74.1 89.5
590 225.4 175.0
638 277.2 167.0
305 178.5 68.2
229 47.0 54.6
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Fig. 5. Box plot of the maturation and healing indices (the rectangles represent 95%
F
pFig. 3. Distributions of the lengthening objectives.
ean preoperative valgus deviation was 8.7±5.6◦ (range: 4–15◦)
ersus 3±1.2◦ (range: 0–5◦) postoperatively and the preoperative
arus deviationwas 13±8.1◦ (range: 4–20◦) versus a postoperative
eviation of 2.1±1.4◦ (range: 0–5◦)..6. Joint range of movement
The functional results were excellent in 21 patients, good in one
ase, andpoor in one case. Themean functional scorewas 85.4±4.3
ig. 4. Preoperative, immediate postoperative X-rays as well as at the end of distraction
ost-traumatic length discrepancy.of the population and the segments the extreme values; the bold line represents the
median).
(range: 50–100). The knee range of movement was deemed normal
in 21 cases; one patient presented a ﬂexion limitation at 70◦ with
an extension at 0◦ and another patient ﬂessum at 10◦ with ﬂexion
at 140◦.
3.7. Complications
A single intraoperative complication was observed: an inter-
condylar fracture during placement of the femoral nail via the
retrograde approach. This complication, detected during the
intervention, required percutaneous screw ﬁxation (with no con-
sequence on the course of the lengthening procedure).
and at 2 years of follow-up for one patient who underwent lengthening for 50mm
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iPostoperatively, according to the Paley classiﬁcation, in eight
atients, ﬁve problems were observed (Lascombes grade 1), two
bstacles (grade 2), and one major complication (grade 4). The
ve problems were two postoperative hematomas, two equinus
eformities at the end of lengthening, and one complex regional
ain syndrome that required physical therapy. One patient pre-
ented dysfunctioning of the transmitter allowing the lengthening
f the nail, which had to be replaced. One patient having under-
one several surgeries presented cutaneous necrosis requiring ﬂap
overage. Finally, one patient decompensated an arteriovenous ﬁs-
ula of the posterior tibial artery during tibial lengthening and an
mbolization procedure had to be performed.
. Discussion
This study highlights the good results of the Fitbone® lower-
imb lengthening technique with 88% reliability in terms of
btaining the planned lengthening and a 95% rate of good or
xcellent functional results. However, the number of complications
emains high with a 15.3% rate.
This study presents a certain number of limitations. First, the
umber of patients included was limited (23 patients). This study
id not include a group of control patients that would have made
t possible to compare the results of this bone lengthening tech-
iquewith conventional techniques. Finally, this study included the
echnique’s learning curve marked by the occurrence of an intra-
perative intercondylar fracture that could probably have been
voided with more experience.
Inaddition, usingan intramedullarynail presents certain techni-
al limitations. To correct the bone length in the three planes, rigid
eamers are required, which makes it impossible to follow the line
ith the least possible resistance and therefore to guide reaming
ccording to the position selected during the planning stage. Thus,
onsidering the minimum diameter of a Fitbone® TAA nail at 11
m, this was the greatest limitation in the use of this type of sys-
em. The need to make the osteotomy line between 7 and 11 cm
rom the joint space to ensure solid nail locking is also a limitation.
arge angular deformities with a center of rotation and angulation
CORA) very distant from the osteotomy are also geometric aspects
hat may make use of the lengthening systems impossible. Finally,
reoperative planning requires being highly rigorous and very pre-
ise because, contrary to bone lengthening systems using external
xators, no adjustment can be made postoperatively. The use of
one lengthening nails in children remains limited because of the
resence of the growth plates, although some authors, in rare cases
f children treated for tumors, report no complications when the
mplant had a smooth coating and was inserted in the central part
f the physis [13,14].
The complication rate of bone lengthening procedures accord-
ng to the length achieved and surgeon experience ranged from24%
o 117% for external ﬁxation [10,12,15,16] and from 11% to 47% for
ntramedullary lengthening systems [3,17–19]. For external ﬁxa-
ors it has been clearly established that the complication rate varies
n adults depending onpatient age, the length of the procedure, and
he number of wires put in place [12,15]. In children, the amount
f lengthening does not seem to be a limiting factor, contrary to
he correction of an angulation deformity, which seems to worsen
he resultswhen it is greater than 30◦ [20].Mechanical lengthening
ails such as the ISKD® and Albizzia® require rotation movements
o lengthen the limb, which can cause pain and discomfort. A con-
iderable number of patients with the Albizzia nail (22–39%) have
ad to be rehospitalized so that the rotational movements could be
one under anesthesia [17,18,21].
The complication rate in series in which the Albizzia® lengthen-
ngnailwas used vary from22% to 29% if these cases ofmobilizationunder anesthesia are not taken into account [17,18]. As for the
ISKD® nail, the mobilization rate under anesthesia is around 27%
and the complication rate varies from 11% to 48% depending on the
study [3,19]. The main problem with the ISKD® nail is the absence
of reliable control of the lengthening and its speed [22]. Recently,
a new lengthening system called the Precice® nail (Ellipse Tech-
nologies, Inc, Irvine, CA, USA) was used in a series of 24 patients.
Compared to the mechanical systems, this system presents the
advantage of controlling lengthening with an electromagnetic sys-
tem. However, other than a high material breakage rate (4%),
the lengthening procedures require being supervised by the sur-
geon, which is a signiﬁcant deterrent to its use [23]. Moreover,
the instrumentation of this implant does not include a system
of working tubes guaranteeing a minimally invasive implantation
and uses ﬂexible reamers for a straight implant, which remains
debatable.
Our complication rate with the Fitbone® nail was 15.4%, slightly
higher than what has been reported in the literature. Krieg et al.
[6] reported a 12.5% complication rate, while Baumgart et al. [7]
reported a 13% complication rate in a large series of 150 patients.
These low complication rates can be explained in part by controlled
and progressive lengthening procedures. In addition, technical
complications or material failure seem to be rare events with the
Fitbone® nail, in both our experience and the studies reported in
the literature [8,24–26]. Baumgart et al. reported a 6% rate of tech-
nical incidents and a material failure rate of 3% [7]. We observed
no loss of lengthening related to telescoping of the nail or fracture
of the locking screws, but Krieg et al. [6] report three incidents of
this type. It should be noted that in their study Krieg et al. [6] used
the ﬁrst generation of the Fitbone® nail, which did not provide an
anti-telescoping component.
As for bone healing, intramedullary lengthening systems do not
seem to disturb bone formation at the lengthening callus. Ilizarov
emphasized the importance of preserving endosteal vasculariza-
tion for osteogenesis of the distraction calluses during lengthening
procedures using external ﬁxators [27–29]. Donnan et al. [20]
reported a mean healing index of 43.6 days/cm in children treated
with external ﬁxators. The Albizzia nail is reported to present a
more rapid healing index of 35.2 days/cm [17] and the ISKD nail an
index varying from 21 to 29 days/cm [19,30]. For the Fitbone® nail,
the healing indices reported range from 48 days/cm to 26 days/cm
[6,7]. The slowest indices are observed in particular for the length-
ening procedures involving the tibia [7]. The present study found
a mean healing index of 73 days/cm for femurs and 83.5 days/cm
for tibias. This difference compared to the data reported in the lit-
erature can be explained partly by the fact that the mean age of
our patients was much older than the age of patients in the other
studies, which investigated mainly adolescents and young adults.
In addition, the mean target lengthening in the present series was
much longer than in other studies.
The short hospital stay and the rapid return to walking are
important aspects arguing in favor of the Fitbone® long-bone
lengthening systems. The absence of wires transﬁxing the muscles
and skin make early rehabilitation possible during the distraction
phase. In addition, during this phase patients can resume partial
weightbearing at 20 kg and be mobilized immediately. Weight-
bearing is increased monthly depending on the progression of the
callus. These advantages are to be compared to the restrictions
of external ﬁxators, a source of discomfort related to bone wire
care, clothing restrictions, and pain related to the transﬁxing wires,
reducing mobilization and in the end the return to daily and occu-
pational activities [5,31,32].
In conclusion, this study demonstrates the good short-term
results with the Fitbone® nail from both reliability and clinical
points of view. Assessment on a larger group of patients remains
necessary but limited by the cost of this type of device.
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